Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Charly50on Mar 24, 2021 4:22am
235 Views
Post# 32864477

faire Diskussion

faire Diskussion
If the aim is to advance Sernova with his science and medicine, then it is allowed to ask uncomfortable questions. P has done a great job and capital is certainly needed. The conditions of the financial deal were at the lowest end of all possibilities at this point in time and I am firmly convinced that this setback to 1.20 should not have been.
Well now it is like that.
I hope that future decisions of this kind will be avoided in the future.
It is absolutely necessary to have good bookkeeping (financial advisor) in addition to good craftsmanship.
I wish for an open, transparent and fair dealings with us shareholders. Not just L.J. wants to know how our capital works.
Since then he has been walking around with a big grin on his face.
We all want that, but above all the many insulin-dependent patients who are entitled to this news.
<< Previous
Bullboard Posts
Next >>